Kaine presses Pence on Trump's tweets to "LIBERATE" states [CBS News]

Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: CBS News
with Democratic governorsBy Grace SegersApril 17, 2020 / 4:29 PM experts raise concerns about reopeningDuring a conference call with Democratic senators and members of the Task Force Friday, Virginia Senator Tim Kaine, a Democrat, questioned Vice President Mike Pence about President Trump's recent tweets calling to "LIBERATE" states that have Democratic governors — including Kaine's home state of Virginia.In his tweets, Mr. Trump also advocated "liberating"MichiganMinnesota"LIBERATE VIRGINIA, and save your great 2nd Amendment. It is under siege!" Mr. Trumpwrote: The Race To Respond updates: U.S. death toll nears 35,000 in : The Race To RespondAccording to two Democratic aides who were on the call, which was about the administration's response to thecoronavirus pandemicKaine "asked Pence why the president was trying to incite division in the midst of a global pandemic," one of the aides said."Pence tried to duck out of it by talking about how they are working respectfully with governo
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Initiates New Intravascular Lithotripsy Clinical Trial to Improve Outcomes in Patients with Coronary Artery DiseasePR Newswire
- Laboratory Robotics Market Set to Grow at 6.6% CAGR, Reaching US$ 548.6 Million by 2034 Amid Increasing Adoption in Pharma and Biotech | Transparency Market Research, Inc. [Yahoo! Finance]Yahoo! Finance
- Here's How Many Shares of AbbVie You Need to Own to Get $1,000 in Yearly Dividends [Yahoo! Finance]Yahoo! Finance
- Cardiac Biomarkers Market to be Worth $10.08 Billion by 2031--Exclusive Report by Meticulous Research® [Yahoo! Finance]Yahoo! Finance
- Nearly 20 infant formulas found to contain toxic lead, arsenic, or both. Here's how parents can keep babies safe [Fortune]Fortune
ABT
Earnings
- 1/22/25 - In-Line
ABT
Sec Filings
- 3/14/25 - Form ARS
- 3/14/25 - Form DEFA14A
- 3/14/25 - Form DEF
- ABT's page on the SEC website